PT M Cash Integrasi Tbk (IDX:MCAS)
Indonesia · Delayed Price · Currency is IDR 990.00
-35.00 (-3.41%)
Aug 1, 2025, 3:48 PM WIB
Theseus Pharmaceuticals Cash Flow Statement
Financials in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | -8,281 | -15.54 | 540.85 | 24,814 | 63,078 | 25,639 | Upgrade |
Depreciation & Amortization | 89,528 | 89,528 | 68,777 | 51,955 | 31,480 | 16,772 | Upgrade |
Other Amortization | 7,821 | 7,821 | 7,143 | 4,597 | 3,884 | - | Upgrade |
Other Operating Activities | -122,359 | -135,305 | 9,307 | 18,728 | 175,418 | -55,060 | Upgrade |
Operating Cash Flow | -33,292 | -37,972 | 85,767 | 100,094 | 273,860 | -12,648 | Upgrade |
Operating Cash Flow Growth | - | - | -14.31% | -63.45% | - | - | Upgrade |
Capital Expenditures | -34,371 | -39,463 | -100,662 | -55,220 | -79,786 | -57,393 | Upgrade |
Sale of Property, Plant & Equipment | 299.87 | 310.03 | 860.8 | 4,303 | 1,170 | 8,631 | Upgrade |
Cash Acquisitions | - | -432.45 | -127,004 | -242,189 | -102,293 | -648,551 | Upgrade |
Divestitures | 8,714 | - | - | 12,447 | 83,697 | 201,193 | Upgrade |
Sale (Purchase) of Intangibles | -1,044 | -4,072 | -2,928 | -7,058 | -9,861 | -18,308 | Upgrade |
Investment in Securities | -32.21 | -22.2 | 15,081 | 161,007 | -184,164 | 367,787 | Upgrade |
Other Investing Activities | -8,139 | 28,239 | -11,338 | 32,500 | -18,600 | 7,613 | Upgrade |
Investing Cash Flow | -34,571 | -15,441 | -225,990 | -94,210 | -309,837 | -139,029 | Upgrade |
Short-Term Debt Issued | - | 62,940 | 73,601 | 342,975 | 109,820 | 50,661 | Upgrade |
Long-Term Debt Issued | - | 1,873,080 | 858,162 | 794,082 | 652,841 | 590,513 | Upgrade |
Total Debt Issued | 1,449,340 | 1,936,020 | 931,763 | 1,137,058 | 762,661 | 641,175 | Upgrade |
Short-Term Debt Repaid | - | -86,502 | -135,232 | -347,004 | -37,150 | -19,020 | Upgrade |
Long-Term Debt Repaid | - | -1,856,167 | -705,949 | -828,385 | -680,125 | -627,687 | Upgrade |
Total Debt Repaid | -1,462,062 | -1,942,668 | -841,181 | -1,175,389 | -717,276 | -646,707 | Upgrade |
Net Debt Issued (Repaid) | -12,722 | -6,648 | 90,582 | -38,331 | 45,385 | -5,533 | Upgrade |
Issuance of Common Stock | - | - | - | - | - | 34,940 | Upgrade |
Repurchase of Common Stock | -787.38 | -150.96 | - | - | - | -12,457 | Upgrade |
Other Financing Activities | 21,436 | -938.67 | - | -26,993 | 37,502 | -66,168 | Upgrade |
Financing Cash Flow | 7,926 | -7,738 | 90,582 | -65,324 | 82,887 | -49,219 | Upgrade |
Miscellaneous Cash Flow Adjustments | - | -778.2 | - | -4,260 | -2,118 | - | Upgrade |
Net Cash Flow | -59,936 | -61,929 | -49,641 | -63,700 | 44,792 | -200,896 | Upgrade |
Free Cash Flow | -67,662 | -77,436 | -14,895 | 44,875 | 194,074 | -70,042 | Upgrade |
Free Cash Flow Growth | - | - | - | -76.88% | - | - | Upgrade |
Free Cash Flow Margin | -1.26% | -1.08% | -0.13% | 0.36% | 1.53% | -0.62% | Upgrade |
Free Cash Flow Per Share | -78.36 | -89.22 | -17.16 | 51.70 | 223.60 | -80.70 | Upgrade |
Cash Interest Paid | 19,720 | 19,720 | 17,981 | 18,534 | 19,011 | 19,289 | Upgrade |
Cash Income Tax Paid | - | -20,744 | 39,443 | 31,078 | 19,136 | 44,392 | Upgrade |
Levered Free Cash Flow | 3,969 | -29,400 | 38,128 | 82,808 | 99,217 | -113,057 | Upgrade |
Unlevered Free Cash Flow | 16,423 | -17,075 | 49,366 | 94,392 | 111,099 | -101,001 | Upgrade |
Change in Net Working Capital | 32,704 | 65,082 | -60,305 | -66,849 | -111,560 | 114,296 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.